EMA — authorised 15 November 2013
- Marketing authorisation holder: JANSSEN-CILAG INTERNATIONAL NV
- Status: approved
🇪🇺 Invokana in European Union
EMA authorised Invokana on 15 November 2013
Marketing authorisation
Invokana in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Invokana approved in European Union?
Yes. EMA authorised it on 15 November 2013.
Who is the marketing authorisation holder for Invokana in European Union?
JANSSEN-CILAG INTERNATIONAL NV holds the EU marketing authorisation.